Clinical Research, Pharma & Healthcare Financing Category Archives - Page 35 Of 37

Clinical Research, Pharma & Healthcare Financing

NationsBenefits® Expands Retail Network with Walgreens

Business WireFebruary 18, 2025August 1, 2025

by Business WireFebruary 18, 2025August 1, 20250215

NationsBenefits®, the leading healthcare fintech, supplemental benefits, and outcomes platform, announced their latest retail integration with Walgreens, one of the nation’s leading integrated healthcare and pharmacy...

Clinical Research, Pharma & Healthcare Financing

European Commission Approves CSL & Arcturus’ KOSTAIVE®

Business WireFebruary 17, 2025August 1, 2025

by Business WireFebruary 17, 2025August 1, 20250204

KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA COVID-19...

Clinical Research, Pharma & Healthcare Financing

ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research

Business WireFebruary 17, 2025August 1, 2025

by Business WireFebruary 17, 2025August 1, 20250191

Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics...

Clinical Research, Pharma & Healthcare Financing

Pfizer’s TALZENNA® + XTANDI® Improve Survival in Prostate Cancer

Business WireFebruary 14, 2025August 1, 2025

by Business WireFebruary 14, 2025August 1, 20250200

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with...

Clinical Research, Pharma & Healthcare Financing

Devonian Reports Positive Results in MASH Liver Study

Business WireFebruary 14, 2025August 1, 2025

by Business WireFebruary 14, 2025August 1, 20250266

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today...

Clinical Research, Pharma & Healthcare Financing

Update on Phase 3 Study of E. coli Vaccine Candidate

GlobeNewswireFebruary 13, 2025August 1, 2025

by GlobeNewswireFebruary 13, 2025August 1, 20250326

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted...

Clinical Research, Pharma & Healthcare Financing

Santhera Announces AGAMREE® Reimbursement Agreement in Germany

GlobeNewswireFebruary 13, 2025August 1, 2025

by GlobeNewswireFebruary 13, 2025August 1, 20250238

Ad hoc announcement pursuant to Art. 53 LR Santhera Pharmaceuticals (SIX: SANN), a specialty pharmaceutical company focused on rare diseases, today announces an agreement with...

Clinical Research, Pharma & Healthcare Financing

Cytovation Appoints Martin Dewhurst to its Board of Directors

GlobeNewswireFebruary 13, 2025August 1, 2025

by GlobeNewswireFebruary 13, 2025August 1, 20250207

Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces the appointment of Mr. Martin Dewhurst to...

Clinical Research, Pharma & Healthcare Financing

PulseSight Announces Series A Close to Fund PST-611 in AMD

GlobeNewswireFebruary 13, 2025August 1, 2025

by GlobeNewswireFebruary 13, 2025August 1, 20250265

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its Series A...

Clinical Research, Pharma & Healthcare Financing

AdvanCell Partners with Lilly to Advance Targeted Alpha Therapies

Business WireFebruary 11, 2025August 1, 2025

by Business WireFebruary 11, 2025August 1, 20250214

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli...

Clinical Research, Pharma & Healthcare Financing

Pfizer and Astellas’ PADCEV® + KEYTRUDA® Shows Long-Term Efficacy

Business WireFebruary 11, 2025August 1, 2025

by Business WireFebruary 11, 2025August 1, 20250294

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3...

Clinical Research, Pharma & Healthcare Financing

Citruslabs: UK Wellness Brands Must Prioritise Science-backed Products

Business WireFebruary 11, 2025August 1, 2025

by Business WireFebruary 11, 2025August 1, 20250200

– Citruslabs, one of the leading CROs for consumer brands in the US, is expanding its services to the UK, which has a health and wellness...

Clinical Research, Pharma & Healthcare Financing

AceLink Presents Phase 2 Results of AL01211 for Fabry Disease

Business WireFebruary 10, 2025August 1, 2025

by Business WireFebruary 10, 2025August 1, 20250321

AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim data from its ongoing Phase 2 clinical study of...

Clinical Research, Pharma & Healthcare Financing

Response Pharma Completes Phase 2 Enrollment for RDX-002

Business WireFebruary 7, 2025August 1, 2025

by Business WireFebruary 7, 2025August 1, 20250264

Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a...

Clinical Research, Pharma & Healthcare Financing

Be Biopharma Publishes Study on Engraftment of Plasma Cells

Business WireFebruary 7, 2025August 1, 2025

by Business WireFebruary 7, 2025August 1, 20250283

Publication Demonstrates Engraftment of 20% of Infused Cells without Preconditioning with Consistent Distribution Upon Redosing Manuscript Published in the Molecular Therapy Journal Be Biopharma, Inc....

Category : Clinical Research, Pharma & Healthcare Financing

NationsBenefits® Expands Retail Network with Walgreens

European Commission Approves CSL & Arcturus’ KOSTAIVE®

ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research

Pfizer’s TALZENNA® + XTANDI® Improve Survival in Prostate Cancer

Devonian Reports Positive Results in MASH Liver Study

Update on Phase 3 Study of E. coli Vaccine Candidate

Santhera Announces AGAMREE® Reimbursement Agreement in Germany

Cytovation Appoints Martin Dewhurst to its Board of Directors

PulseSight Announces Series A Close to Fund PST-611 in AMD

AdvanCell Partners with Lilly to Advance Targeted Alpha Therapies

Pfizer and Astellas’ PADCEV® + KEYTRUDA® Shows Long-Term Efficacy

Citruslabs: UK Wellness Brands Must Prioritise Science-backed Products

AceLink Presents Phase 2 Results of AL01211 for Fabry Disease

Response Pharma Completes Phase 2 Enrollment for RDX-002

Be Biopharma Publishes Study on Engraftment of Plasma Cells

emagine Acquires Waada The Movement, Boosts Advisory Capabilities

Milliman: Pension Funding Hits 25-Year High After Market...

Flywire’s UK Conference Highlights Innovation in Higher Education

SCTE TechExpo26: AMC Networks Co-Hosts with Charter

Bronstein Urges Boston Scientific Investors to Act in...

Quick Links

Stay up to date